Roy Dupuis
Tracked across 2 events · 13 articles · First seen May 29, 2026 · Last active Aug 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Roy Dupuis is the Chief Financial Officer of Kane Biotech and is among the recipients of the stock options.
May 29, 2026 · 6 articles
Business
Impact: Roy Dupuis, CFO, is mentioned as a contact but has no direct role in the strategic review announcement.
Aug 05, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Roy Dupuis live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard